Calcium influx via L-type calcium channels in osteoblast cells causes a rapid (in seconds) elevation in intra-A newly described function of 1␣,25-D 3 1 and its analogues is the rapid (in seconds) regulation of intracellular calcium concentration, first reported in chicken duodenum (1) and later in bone osteoblast cells (2-12). It has been documented by patch clamp recordings of whole-cell barium currents (2, 3), by 45 Ca 2ϩ uptake (5, 7), and by fluorescence measurements of intracellular calcium, using the calcium indicator acetoxymethyl Quin2 (10), that 1␣,25-D 3 (2) and other vitamin D 3 metabolites (3,5,7,8,(12)(13)(14) stimulate calcium influx into rat osteosarcoma cells (2,3,5,7,8,12,14) and human and rat osteoblasts (4, 6) in primary culture. Guggino et al. (15) and Caffrey and FarachCarson (2) have shown the presence of L-type calcium channels in ROS 17/2.8 osteoblast-like osteosarcoma cells. These channels, first described in nerve, brain, cardiac and skeletal muscle, are voltage-dependent, conduct barium and calcium, and are blocked by the dihydropyridine antagonist nitrendipine, blocked by the phenylalkylamine antagonist verapamil, and stimulated by the dihydropyridine agonist BayK 8644 (16 -19 influx into ROS 17/2.8 cells yet bound poorly to the nuclear VDR of ROS 17/2.8. Yukihiro et al. (3) reported that the potentiation of calcium channels by these analogues is not compatible with VDR being involved in signal transduction because the structural features like double bonds at carbon 16 and 23 (25-hydroxy-16,23E-diene-D 3 ) (Fig. 1, A-C) or addition of a hydroxyethyl group at the 1-carbon position (1-(1Ј-hydroxyethyl)-25-hydroxy-D 3 ), which cause activation of rapid calcium signal transduction (5), virtually eliminate binding to VDR (3).Although it has been reported that 1␣,25-D 3 and several analogues potentiate calcium channel openings, some vitamin D 3 analogues with inhibitory effects have also been reported.